XBiotech (XBIT)

XBiotech (XBIT) – FDA

Aug 8, 2023 11:48 AM XBiotech (XBIT) Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial
May 22, 2023 09:00 AM XBiotech (XBIT) Announces FDA Authorization of Phase II Study for Natrunix
Apr 28, 2022 09:01 AM
Feb 2, 2022 09:01 AM
Dec 13, 2021 08:46 AM
Apr 19, 2021 05:50 AM
Jan 21, 2021 08:18 AM
Nov 19, 2020 08:16 AM
Sep 21, 2020 08:20 AM
Aug 24, 2020 08:41 AM
Aug 24, 2020 08:11 AM
Aug 17, 2020 08:21 AM
Jul 14, 2020 09:27 AM
May 1, 2020 09:27 AM
Nov 19, 2019 08:56 AM
Nov 12, 2019 08:48 AM
May 23, 2019 08:23 AM
May 2, 2019 08:29 AM
Mar 5, 2019 08:17 AM
Mar 1, 2019 11:46 AM
Jan 23, 2019 08:34 AM
Dec 13, 2018 08:01 AM
Dec 12, 2018 08:32 AM
Oct 5, 2018 08:01 AM
Sep 24, 2018 08:36 AM
Sep 13, 2018 08:02 AM
Aug 27, 2018 08:02 AM
Jul 10, 2018 08:01 AM
May 22, 2018 08:09 AM
Apr 16, 2018 08:10 AM
Apr 2, 2018 08:02 AM
Jan 26, 2018 08:03 AM
Dec 4, 2017 08:03 AM
Nov 14, 2017 07:34 AM
Nov 3, 2017 11:55 AM
Oct 18, 2017 10:43 AM
Sep 20, 2017 08:02 AM
Jun 9, 2017 03:04 PM
Jun 1, 2017 08:39 AM
May 19, 2017 07:49 AM
May 18, 2017 04:35 PM
Apr 21, 2017 06:20 AM
Apr 3, 2017 08:03 AM
Mar 27, 2017 01:14 PM
Jan 17, 2017 08:14 AM
Dec 16, 2016 12:59 PM
Jul 5, 2016 10:48 AM
Jul 5, 2016 06:36 AM
May 24, 2016 08:02 AM
May 19, 2016 11:15 AM